David W. Gryska, Director at PDL BIOPHARMA, INC. (PDLI), sold 75,000 shares at $2.68 ($201K) on 2020-12-16, disclosed to the SEC on 2020-12-17.
Open-market sale of $201k PDLI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SGEN | SELL | 2022-11-15 | $968K | — | Filing → |
| SGEN | SELL | 2022-04-21 | $1.2M | — | Filing → |
| SGEN | SELL | 2022-02-09 | $1.1M | — | Filing → |